13.23 USD
↘ 0.04 (0.30%)AT CLOSE (11:59 AM EDT)
Atrium Therapeutics, Inc. Common Stock
RNANASDAQ • USD
13.22
↘ 0.01 (0.08%)
POST MARKET (AS OF 07:40 PM EDT)
Post Market
AS OF 07:40 PM EDT
13.22
↘ 0.01 (0.08%)
Market: CLOSED
Open?$13.48
High?$13.97
Low?$13.04
Prev. Close?$13.27
Volume?234.4K
Avg. Volume?N/A
VWAP?$13.32
Bid / Ask
Bid?$11.19 × 100
Ask?$15.42 × 100
Spread?$4.23
Midpoint?$13.31
Valuation & Ratios
Market Cap?226.3M
Shares Out?17.1M
Float?16.2M
Float %?94.9%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.
Themes
Employees
391
Market Cap
226.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2026-02-27
Address
3020 CALLAN ROAD
SAN DIEGO, CA 92121
Phone: 858-401-7900
SAN DIEGO, CA 92121
Phone: 858-401-7900
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...